Evidence map›Paper›PMID 37686470›Full record

ArticleInternational journal of molecular sciences2023

Easy and Versatile Technique for the Preparation of Stable and Active Lipase-Based CLEA-like Copolymers by Using Two Homofunctional Cross-Linking Agents: Application to the Preparation of Enantiopure Ibuprofen.

Oussama Khiari, Nassima Bouzemi, José María Sánchez-Montero, Andrés R Alcántara

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Editorial of Special Issue "Current Trends in Chemistry Towards Biology".International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oussama KhiariEco Compatible Asymmetric Catalysis Laboratory (LCAE), Department of Chemistry, Badji Mokhtar University, Annaba 23000, Algeria.
Nassima BouzemiEco Compatible Asymmetric Catalysis Laboratory (LCAE), Department of Chemistry, Badji Mokhtar University, Annaba 23000, Algeria.
José María Sánchez-MonteroDepartment of Chemistry in Pharmaceutical Sciences, Pharmacy Faculty, Complutense University of Madrid (UCM), Ciudad Universitaria, Plaza de Ramon y Cajal, s/n., 28040 Madrid, Spain.
Andrés R AlcántaraDepartment of Chemistry in Pharmaceutical Sciences, Pharmacy Faculty, Complutense University of Madrid (UCM), Ciudad Universitaria, Plaza de Ramon y Cajal, s/n., 28040 Madrid, Spain.ORCID 0000-0003-4856-4000

Funding

Spanish Ministry of Science and Innovation PID2019-105337RB-C22
6 · The paper itself

Abstract

An easy and versatile method was designed and applied successfully to obtain access to lipase-based cross-linked-enzyme aggregate-like copolymers (CLEA-LCs) using one-pot, consecutive cross-linking steps using two types of homobifunctional cross-linkers (glutaraldehyde and putrescine), mediated with amine activation through pH alteration (pH jump) as a key step in the process. Six lipases were utilised in order to assess the effectiveness of the technique, in terms of immobilization yields, hydrolytic activities, thermal stability and application in kinetic resolution. A good retention of catalytic properties was found for all cases, together with an important thermal and storage stability improvement. Particularly, the CLEA-LCs derived from

Indexed as

IbuprofenLipaseAminesCatalysisHydrolysisPolymersAminesIbuprofenLipasePolymersamine activationCLEA-like copolymerscross-linkersenzymatic hydrolysisibuprofen resolutionone-pot immobilizationpH jump

Identifiers

PMID37686470
PMCPMC10487927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.